Finance

Lists
688091:SHA
Shanghai Yizhong Pharmaceutical Co Ltd
35,07 CN¥
+0,06%
(+0,020) 1D
16 қаз., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688091...
Open
35,38 CN¥
High
36,26 CN¥
Low
34,96 CN¥
Mkt. cap
7,25 млрд
Avg. vol.
2,77 млн
Volume
1,78 млн
P/E ratio
104,89
52-wk high
66,20 CN¥
52-wk low
33,80 CN¥
EPS
0,33 CN¥
No. of employees
457
Open
35,38 CN¥
High
36,26 CN¥
Low
34,96 CN¥
Mkt. cap
7,25 млрд
Avg. vol.
2,77 млн
Volume
1,78 млн
P/E ratio
104,89
52-wk high
66,20 CN¥
52-wk low
33,80 CN¥
EPS
0,33 CN¥
No. of employees
457
News stories
From web sources and news partners
About Shanghai Yizhong Pharmaceutical Co Ltd
CEO-
Employees457
Founded2009 ж. 10 қыр.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
82,82 млн
72,95 млн
79,16 млн
86,68 млн
Cost of goods sold
12,69 млн
14,03 млн
11,67 млн
13,29 млн
Cost of revenue
12,69 млн
14,03 млн
11,67 млн
13,29 млн
Research and development expenses
25,74 млн
31,86 млн
27,36 млн
24,62 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39,43 млн
18,74 млн
27,51 млн
29,89 млн
Operating expense
66,07 млн
51,41 млн
55,17 млн
55,98 млн
Total operating expenses
78,76 млн
65,44 млн
66,84 млн
69,27 млн
Operating income
4,06 млн
7,51 млн
12,32 млн
17,41 млн
Other non operating income
-1,06 млн
1,06 млн
-1,93 мың
-1,23 мың
EBT including unusual items
9,16 млн
11,83 млн
16,96 млн
24,37 млн
EBT excluding unusual items
7,11 млн
12,82 млн
17,38 млн
21,10 млн
Income tax expense
-3,50 млн
-2,07 млн
-1,21 млн
229,63 м.
Effective tax rate
-38,19%
-17,51%
-7,13%
0,94%
Other operating expenses
368,20 м.
340,52 м.
-202,15 м.
1,03 млн
Net income
12,65 млн
13,90 млн
18,17 млн
24,14 млн
Net profit margin
15,28%
19,05%
22,95%
27,85%
Earnings per share
-
-
-
-
Interest and investment income
4,10 млн
4,34 млн
5,18 млн
3,80 млн
Interest expense
-
-85,85 мың
-112,57 м.
-113,68 м.
Net interest expenses
4,10 млн
4,25 млн
5,06 млн
3,69 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
6,85 млн
10,50 млн
15,31 млн
20,71 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары